Published • loading... • Updated
Long-Acting Therapies Trials Tracker for Malaria, Hepatitis C Virus, and Opioid Use and Overdose Prevention
Summary by hepCoalition
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Long-Acting Therapies Trials Tracker for Malaria, Hepatitis C Virus, and Opioid Use and Overdose Prevention
Treatment Action Group releases a trials tracker providing a compilation of ongoing clinical trials on long-acting therapies for HCV, malaria, and opioid use and overdose prevention therapy in the R&D pipeline. LAT CAB (2021-present) / Low- and middle-income countries, Harm reduction, Long-acting technologies
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
